Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 106 Specimen Handling 87 pembrolizumab 81 enzalutamide 64 Nivolumab 62 Gemcitabine 59 Docetaxel 51 Abiraterone Acetate 44 apalutamide 43 Radiosurgery 43 Androgen Antagonists 43 Prednisone 42 darolutamide 40 Cisplatin 38 Biopsy 36 Radiotherapy 34 cabozantinib 32 Carboplatin 30 abiraterone 29 Pluvicto 29 Ipilimumab 29 durvalumab 25 Leuprolide 24 enfortumab vedotin 23 X-Rays 23 Radiation 23 olaparib 20 atezolizumab 20 Standard of Care 20 avelumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Atorvastatin × Genitourinary × 90 days × Clear all

NCT03819101 2026-05-06

PEACE-4

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡